Literature DB >> 3812894

Factors affecting the morbidity of elective liver resection.

R E Stimpson, C A Pellegrini, L W Way.   

Abstract

To identify the determinants of morbidity and mortality after hepatic lobectomy, we studied 17 potential risk factors in 58 consecutive patients who had right hepatic lobectomy (39 patients), left hepatic lobectomy (10 patients), extended right hepatic lobectomy (6 patients), and left lateral segmentectomy (3 patients). The lesions were benign neoplasm (11 patients), primary malignancy (12 patients), metastatic neoplasm (28 patients), and inflammatory conditions, namely, stones, ductal strictures, and abscess (7 patients). Two patients died (3.8 percent), one from operative hemorrhage and the other from sepsis. Major complications occurred in 29 patients (50 percent). The presence of diabetes or pulmonary disease correlated with the development of complications. Infection occurred in four of five patients with diabetes. The incision was extended into the thorax in nine patients, all of whom had complications. The mean weight of the resected specimen did not differ between patients who underwent thoracotomy and those who did not, but the two largest specimens (over 2 kg) were removed without thoracotomy. Minor complications developed in two patients with benign tumors. Biliary fistulas developed in three of seven patients with inflammatory conditions. Infectious complications were decreased in the presence of adequate perioperative antibiotics and closed drainage of the subphrenic space. These data show that in fit patients, elective liver resection can be performed with a low morbidity and mortality; diabetes, pulmonary disease, and inflammatory lesions increase the risk of hepatic resections; adequate antibiotics and closed drainage decrease the risk of infection; and thoracotomy markedly increases the chance of complications. Finally, since elective resection can nearly always be performed without thoracotomy, it should be avoided in most patients.

Entities:  

Mesh:

Year:  1987        PMID: 3812894     DOI: 10.1016/0002-9610(87)90812-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

1.  Hepatic resection at a community hospital.

Authors:  M E Ston; S U Rehman; G Conaway; A Sardi
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

2.  Parenchymal transection with ultrasonic scalpel in liver resection.

Authors:  O Abbasoglu; I Sayek
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

3.  Hepatic resection in the elderly.

Authors:  J G Fortner; R M Lincer
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

4.  Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases.

Authors:  Yoshihiro Mise; Reza J Mehran; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2014-06-20       Impact factor: 3.982

5.  Should hepatic resections be performed at high-volume referral centers?

Authors:  M A Choti; H M Bowman; H A Pitt; J A Sosa; J V Sitzmann; J L Cameron; T A Gordon
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.452

Review 6.  Recurrent pregnancy loss.

Authors:  Evdokia Dimitriadis; Ellen Menkhorst; Shigeru Saito; William H Kutteh; Jan J Brosens
Journal:  Nat Rev Dis Primers       Date:  2020-12-10       Impact factor: 52.329

Review 7.  Has laparoscopy increased surgical indications for benign tumors of the liver?

Authors:  Adriana Toro; Michel Gagner; Isidoro Di Carlo
Journal:  Langenbecks Arch Surg       Date:  2012-10-09       Impact factor: 3.445

8.  Validation of biological and clinical outcome between with and without thoracotomy in liver resection: a matched cohort study.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Masamichi Moriguchi; Shunji Okada; Yuki Hayashi; Hisashi Nakayama; Tokio Higaki; Masahiko Sugitani
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

9.  Pretreatment with enteral cholestyramine prevents suppression of the cellular immune system after partial hepatectomy.

Authors:  P A Van Leeuwen; M A Boermeester; A P Houdijk; S Meyer; M A Cuesta; R I Wesdorp; M L Rodrick; D W Wilmore
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

10.  Hepatic resection for hepatocellular carcinoma. An audit of 343 patients.

Authors:  E C Lai; S T Fan; C M Lo; K M Chu; C L Liu; J Wong
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.